Identification of molecular alterations in gastrointestinal carcinomas and dysplastic hamartomas in Peutz-Jeghers syndrome

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1611-1619

  Korsse, Susanne E ^a   Biermann, Katharina ^a   Offerhaus, G Johan A ^b   Wagner, Anja ^a   Dekker, Evelien ^c   Mathus Vliegen, Elisabeth M H ^c   Kuipers, Ernst J ^a   van Leerdam, Monique E ^a   van Veelen, Wendy ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; K RAS PROTEIN; PROTEIN KINASE LKB1; PROTEIN P53; PROTEIN S6; SMAD4 PROTEIN;

ADULT; ALLELE; ARTICLE; CARCINOGENESIS; FEMALE; GASTROINTESTINAL CARCINOMA; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ADULT; ALLELES; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HAMARTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NETHERLANDS; PEDIGREE; PEUTZ-JEGHERS SYNDROME; PROTEIN-SERINE-THREONINE KINASES; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880310991     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt068     Document Type: Article

References (27)

1. Giardiello, F.M. et al. (2006) Peutz-Jeghers syndrome and management recommendations. Clin. Gastroenterol. Hepatol., 4, 408-415.
2. Hemminki, A. et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature, 391, 184-187.
3. Jenne, D.E. et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet., 18, 38-43.
4. Volikos, E. et al. (2006) LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J. Med. Genet., 43, e18.
5. de Leng, W.W. et al. (2007) Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin. Genet., 72, 568-573.
6. van Lier, M.G. et al. (2011) High cumulative risk of intussusception in patients with Peutz-Jeghers syndrome: time to update surveillance guidelines? Am. J. Gastroenterol., 106, 940-945.
7. Giardiello, F.M. et al. (2000) Very high risk of cancer in familial Peutz- Jeghers syndrome. Gastroenterology, 119, 1447-1453.
8. van Lier, M.G. et al. (2011) High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut, 60, 141-147.
9. Dozois, R.R. et al. (1969) The Peutz-Jeghers syndrome. Is there a predisposition to the development of intestinal malignancy? Arch. Surg., 98, 509-517.
10. Hizawa, K. et al. (1993) Neoplastic transformation arising in Peutz-Jeghers polyposis. Dis. Colon Rectum, 36, 953-957.
11. Latchford, A.R. et al. (2011) Peutz-Jeghers syndrome: intriguing suggestion of gastrointestinal cancer prevention from surveillance. Dis. Colon Rectum, 54, 1547-1551.
12. Gruber, S.B. et al. (1998) Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res., 58, 5267-5270.
13. Entius, M.M. et al. (2001) Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J. Clin. Pathol., 54, 126-131.
14. de Leng, W.W. et al. (2003) Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas. Clin. Cancer Res., 9, 3065-3072.
15. Bardeesy, N. et al. (2002) Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature, 419, 162-167.
16. Miyoshi, H. et al. (2002) Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res., 62, 2261-2266.
17. Klumpen, H.J. et al. (2011) mTOR inhibitor treatment of pancreatic cancer in a patient with Peutz-Jeghers syndrome. J. Clin. Oncol., 29, e150-e153.
18. van Veelen, W. et al. (2011) The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling. Oncogene, 30, 2289-2303.
19. Wei, C. et al. (2005) Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. Cancer Res., 65, 11297-11303.
20. Takeda, H. et al. (2006) Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/-p53-/- compound mutant mice. Oncogene, 25, 1816-1820.
21. Fodde, R. et al. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer, 1, 55-67.
22. Miyaki, M. et al. (2000) Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome. Cancer Res., 60, 6311-6313.
23. Hruban, R.H. et al. (1993) K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol., 143, 545-554.
24. Hezel, A.F. et al. (2008) Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol. Cell. Biol., 28, 2414-2425.
25. Jones, S. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
26. Westerman, A.M. et al. (1999) Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet, 353, 1211-1215.
27. van Wijk, Th. W. (1950) Over het syndroom polyposis adenomatosa gastro- intestinalis generalisata heredofamiliaris gecombineerd met huid- en slijmvliespigmentaties of ziekte van Peutz (thesis). Leiden, the Netherlands.